{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:31:03Z","timestamp":1787697063824,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.humpath.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:49:22Z","timestamp":1566244162000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis"],"prefix":"10.1016","volume":"93","author":[{"given":"Maryam","family":"Shahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Bloechl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel I.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupendra","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Krigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Evasovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.08.010_bb0005","doi-asserted-by":"crossref","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.","DOI":"10.1089\/thy.2015.0020"},{"issue":"8","key":"10.1016\/j.humpath.2019.08.010_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2362.2009.02162.x","article-title":"Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination","volume":"39","author":"Guth","year":"2009","journal-title":"Eur J Clin Invest."},{"issue":"5","key":"10.1016\/j.humpath.2019.08.010_bb0015","first-page":"622","article-title":"American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules\u20142016 update","volume":"22","author":"Gharib","year":"2016","journal-title":"Endocr Pract."},{"issue":"11","key":"10.1016\/j.humpath.2019.08.010_bb0020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1089\/thy.2009.0274","article-title":"The Bethesda system for reporting thyroid cytopathology","volume":"19","author":"Cibas","year":"2009","journal-title":"Thyroid."},{"issue":"2","key":"10.1016\/j.humpath.2019.08.010_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncy.20195","article-title":"Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study","volume":"120","author":"Bongiovanni","year":"2012","journal-title":"Cancer Cytopathol."},{"issue":"4","key":"10.1016\/j.humpath.2019.08.010_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda system for reporting thyroid cytopathology: a meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"acta cytol."},{"issue":"3","key":"10.1016\/j.humpath.2019.08.010_bb0035","first-page":"195","article-title":"The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference","volume":"117","author":"Nayar","year":"2009","journal-title":"Cancer."},{"issue":"4","key":"10.1016\/j.humpath.2019.08.010_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cncy.20091","article-title":"Should \"atypical follicular cells\" in thyroid fine-needle aspirates be subclassified?","volume":"118","author":"Renshaw","year":"2010","journal-title":"Cancer Cytopathol."},{"issue":"11","key":"10.1016\/j.humpath.2019.08.010_bb0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/thy.2009.0155","article-title":"The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution","volume":"19","author":"Theoharis","year":"2009","journal-title":"Thyroid."},{"issue":"5","key":"10.1016\/j.humpath.2019.08.010_bb0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dc.21754","article-title":"The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy","volume":"40","author":"Wu","year":"2012","journal-title":"Diagn Cytopathol."},{"issue":"4","key":"10.1016\/j.humpath.2019.08.010_bb0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5858\/arpa.2017-0174-RA","article-title":"Update on molecular testing for cytologically indeterminate thyroid nodules","volume":"142","author":"Nishino","year":"2018","journal-title":"Arch Pathol Lab Med."},{"issue":"6","key":"10.1016\/j.humpath.2019.08.010_bb0060","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/jc.2009-0247","article-title":"Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules","volume":"94","author":"Nikiforov","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"10.1016\/j.humpath.2019.08.010_bb0065","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.humpath.2019.08.010_bb0070","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/thy.2015.0305","article-title":"Impact of the multigene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance\/follicular lesion of undetermined significance cytology","volume":"25","author":"Nikiforov","year":"2015","journal-title":"Thyroid."},{"issue":"2","key":"10.1016\/j.humpath.2019.08.010_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/dc.2840010208","article-title":"Cytopathology of follicular lesions of the thyroid gland","volume":"1","author":"Kini","year":"1985","journal-title":"Diagn Cytopathol."},{"issue":"8","key":"10.1016\/j.humpath.2019.08.010_bb0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.humpath.2019.08.010_bb0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/thy.2016.0048","article-title":"Correlation between histological diagnosis and mutational panel testing of thyroid nodules: a two-year institutional experience","volume":"26","author":"Shrestha","year":"2016","journal-title":"Thyroid."},{"issue":"9","key":"10.1016\/j.humpath.2019.08.010_bb0090","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.5858\/arpa.2013-0235-CR","article-title":"Triage of cytologic direct smears for ancillary studies: a case-based illustration and review","volume":"137","author":"Roh","year":"2013","journal-title":"Arch Pathol Lab Med."},{"issue":"1","key":"10.1016\/j.humpath.2019.08.010_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/dc.23052","article-title":"Subclassification of \"atypia of undetermined significance\" in thyroid fine-needle aspirates","volume":"42","author":"Wu","year":"2014","journal-title":"Diagn Cytopathol."},{"issue":"6","key":"10.1016\/j.humpath.2019.08.010_bb0100","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dc.23472","article-title":"Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery","volume":"44","author":"Shrestha","year":"2016","journal-title":"Diagn Cytopathol."},{"key":"10.1016\/j.humpath.2019.08.010_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ajcp\/aqy109","article-title":"A proposal for separation of nuclear atypia and architectural atypia in Bethesda category III (AUS\/FLUS) based on differing rates of thyroid malignancy","volume":"151","author":"Johnson","year":"2019","journal-title":"Am J Clin Pathol January"},{"issue":"10","key":"10.1016\/j.humpath.2019.08.010_bb0110","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1245\/s10434-011-1635-1","article-title":"3rd, Zarnegar R. Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies","volume":"18","author":"Kato","year":"2011","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10.1016\/j.humpath.2019.08.010_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cncy.21823","article-title":"Thyroid cytology-nuclear versus architectural atypia within the \"atypia of undetermined significance\/follicular lesion of undetermined significance\" Bethesda category have significantly different rates of malignancy","volume":"125","author":"Gan","year":"2017","journal-title":"Cancer Cytopathol."},{"issue":"5","key":"10.1016\/j.humpath.2019.08.010_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncy.21827","article-title":"Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes","volume":"125","author":"Baca","year":"2017","journal-title":"Cancer Cytopathol."},{"issue":"5","key":"10.1016\/j.humpath.2019.08.010_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncy.21984","article-title":"Different qualifiers of AUS\/FLUS thyroid FNA have distinct BRAF, RAS, RET\/PTC, and PAX8\/PPARg alterations","volume":"126","author":"Bellevicine","year":"2018","journal-title":"Cancer Cytopathol."},{"issue":"10","key":"10.1016\/j.humpath.2019.08.010_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol."},{"issue":"12","key":"10.1016\/j.humpath.2019.08.010_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cncy.21475","article-title":"Morphological parameters able to predict BRAF(V600E)-mutated malignancies on thyroid fine-needle aspiration cytology: our institutional experience","volume":"122","author":"Rossi","year":"2014","journal-title":"Cancer Cytopathol."},{"issue":"12","key":"10.1016\/j.humpath.2019.08.010_bb0140","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","article-title":"BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis","volume":"97","author":"Li","year":"2012","journal-title":"JClin Endocrinol Metab."}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:42Z","timestamp":1758645402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719301431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"alternative-id":["S0046817719301431"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}